{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:21:04Z","timestamp":1792185664317,"version":"4.4.0"},"reference-count":108,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH-NHLBI","award":["2R15HL143545-02"],"award-info":[{"award-number":["2R15HL143545-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Tuberculosis (TB) remains one of the most challenging infectious diseases, with Mycobacterium tuberculosis (Mtb) employing sophisticated mechanisms to evade host immunity and establish persistent infections. This review explores recent advances in understanding Mtb\u2019s immune evasion strategies; granuloma dynamics; and emerging immunotherapeutic approaches. Key findings highlight the manipulation of host autophagy; metabolic reprogramming; and cytokine pathways by Mtb to sustain its survival within host cells. Insights into granuloma formation reveal the critical role of bacterial lipids; immune modulation; and hypoxia-driven dormancy in maintaining chronic infection. Innovative therapeutic strategies, including host-directed therapies; epigenetic interventions; and immunomodulators, hold promise for improving TB management and combating drug-resistant strains. Despite these advancements, significant challenges remain, including the development of effective vaccines; addressing latent TB; and ensuring equitable access to novel treatments. The integration of advanced technologies such as artificial intelligence and multi-omics approaches, alongside global collaboration, is essential to overcome these hurdles. This review underscores the importance of a multidisciplinary approach to tackling TB, with the ultimate goal of eradicating this global health threat.<\/jats:p>","DOI":"10.3390\/ijms26041621","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:20:52Z","timestamp":1739503252000},"page":"1621","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Advances in Host\u2013Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3279-0671","authenticated-orcid":false,"given":"Mohammad J.","family":"Nasiri","sequence":"first","affiliation":[{"name":"Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 19839-69411, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1160","authenticated-orcid":false,"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization, WHO (2024). Global Tuberculosis Report, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/15548627.2021.1938912","article-title":"M. tuberculosis PknG manipulates host autophagy flux to promote pathogen intracellular survival","volume":"18","author":"Ge","year":"2022","journal-title":"Autophagy"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.1800530","article-title":"Mycobacterial PknG Targets the Rab7l1 Signaling Pathway To Inhibit Phagosome\u2013Lysosome Fusion","volume":"201","author":"Pradhan","year":"2018","journal-title":"J. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.chom.2008.03.008","article-title":"Mycobacterium tuberculosis Virulence Is Mediated by PtpA Dephosphorylation of Human Vacuolar Protein Sorting 33B","volume":"3","author":"Bach","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29376","DOI":"10.1074\/jbc.M114.582502","article-title":"Mycobacterium tuberculosis Promotes Anti-apoptotic Activity of the Macrophage by PtpA Protein-dependent Dephosphorylation of Host GSK3\u03b1","volume":"289","author":"Poirier","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19371","DOI":"10.1073\/pnas.1109201108","article-title":"Mycobacterium tuberculosis protein tyrosine phosphatase A disrupts phagosome acidification by exclusion of host vacuolar H+-ATPase","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Puri, R.V., Reddy, P.V., and Tyagi, A.K. (2013). Secreted Acid Phosphatase (SapM) of Mycobacterium tuberculosis Is Indispensable for Arresting Phagosomal Maturation and Growth of the Pathogen in Guinea Pig Tissues. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070514"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1073\/pnas.0409716102","article-title":"Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis","volume":"102","author":"Vergne","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1128\/JB.182.23.6850-6853.2000","article-title":"Secretion of an Acid Phosphatase (SapM) by Mycobacterium tuberculosis That Is Similar to Eukaryotic Acid Phosphatases","volume":"182","author":"Saleh","year":"2000","journal-title":"J. Bacteriol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10096-023-04663-0","article-title":"Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection","volume":"42","author":"Nagdev","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Foulon, M., Listian, S.A., Soldati, T., and Barisch, C. (2022). Conserved Mechanisms Drive Host-Lipid Access, Import, and Utilization in Mycobacterium Tuberculosis and M. marinum. Biology of Mycobacterial Lipids, Elsevier.","DOI":"10.1016\/B978-0-323-91948-7.00011-7"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Simeone, R., Bobard, A., Lippmann, J., Bitter, W., Majlessi, L., Brosch, R., and Enninga, J. (2012). Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death. PLOS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002507"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25649","DOI":"10.1073\/pnas.1910368116","article-title":"The conical shape of DIM lipids promotes Mycobacterium tuberculosis infection of macrophages","volume":"116","author":"Augenstreich","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"Hava","year":"2007","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.chom.2023.09.010","article-title":"Mycobacterium tuberculosis suppresses host DNA repair to boost its intracellular survival","volume":"31","author":"Liu","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2021.2021495","article-title":"The exploitation of host autophagy and ubiquitin machinery by Mycobacterium tuberculosis in shaping immune responses and host defense during infection","volume":"19","author":"Shariq","year":"2022","journal-title":"Autophagy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41564-023-01354-6","article-title":"Autophagy restricts Mycobacterium tuberculosis during acute infection in mice","volume":"8","author":"Golovkine","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110715","DOI":"10.1016\/j.cellsig.2023.110715","article-title":"The dynamics of Mycobacterium tuberculosis phagosome and the fate of infection","volume":"108","author":"Zhang","year":"2023","journal-title":"Cell. Signal."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pellegrini, J.M., Tateosian, N.L., Morelli, M.P., and Garc\u00eda, V.E. (2022). Shedding Light on Autophagy During Human Tuberculosis. A Long Way to Go. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.820095"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e0054921","DOI":"10.1128\/mSphere.00549-21","article-title":"Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 Proteins Inhibit Autophagy by Interaction with Rab1A","volume":"6","author":"Trong","year":"2021","journal-title":"mSphere"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"109956","DOI":"10.1016\/j.intimp.2023.109956","article-title":"Identifying autophagy-related genes as potential targets for immunotherapy in tuberculosis","volume":"118","author":"Xiao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41564-023-01373-3","article-title":"Autophagy is part of the answer to tuberculosis","volume":"8","author":"Deretic","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Typas, D. (2023). Autophagy counteracts Mycobacterium tuberculosis infection at early stages. Nat. Struct. Mol. Biol., 30.","DOI":"10.1038\/s41594-023-01024-5"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"L218","DOI":"10.1152\/ajplung.00162.2017","article-title":"Role of apoptosis and autophagy in tuberculosis","volume":"313","author":"Lam","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1038\/s41564-024-01797-5","article-title":"Mycobacterium tuberculosis virulence lipid PDIM inhibits autophagy in mice","volume":"9","author":"Mittal","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.00269-20","article-title":"Identification of autophagy-inhibiting factors of Mycobacterium tuberculosis by high-throughput loss-of-function screening","volume":"88","author":"Strong","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Anes, E., Pires, D., Mandal, M., and Azevedo-Pereira, J.M. (2023). ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis. Biomolecules, 13.","DOI":"10.20944\/preprints202305.0979.v2"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Passos, B.B., Ara\u00fajo-Pereira, M., Vinhaes, C.L., Amaral, E.P., and Andrade, B.B. (2024). The role of ESAT-6 in tuberculosis immunopathology. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1383098"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Koiri, D., Nandi, M., Hameem, P.M.A., Bhausaheb, A.J., Meher, G., Behura, A., Kumar, A., Choudhary, V., Choubey, S., and Saleem, M. (2024). Real-time visualization reveals Mycobacterium tuberculosis ESAT-6 disrupts phagosome via fibril-mediated vesiculation. bioRxiv.","DOI":"10.1101\/2024.04.19.590309"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Venkatesan, A., Palaniyandi, K., Sharma, D., Bisht, D., and Narayanan, S. (2016). Functional characterization of PknI-Rv2159c interaction in redox homeostasis of Mycobacterium tuberculosis. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.01654"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"111812","DOI":"10.1016\/j.ejmech.2019.111812","article-title":"Novel thiazolidinedione-hydroxamates as inhibitors of Mycobacterium tuberculosis virulence factor Zmp1","volume":"185","author":"Torfs","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"114831","DOI":"10.1016\/j.ejmech.2022.114831","article-title":"Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1 to probe its mechanism of function","volume":"244","author":"Dak","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00430-020-00663-5","article-title":"Structural proteomics, electron cryo-microscopy and structural modeling approaches in bacteria\u2013human protein interactions","volume":"209","author":"Chowdhury","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41564-023-01335-9","article-title":"ATG7 and ATG14 restrict cytosolic and phagosomal Mycobacterium tuberculosis replication in human macrophages","volume":"8","author":"Aylan","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_36","first-page":"E8711","article-title":"Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA","volume":"114","author":"Upadhyay","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Serene, L.G., Webber, K., Champion, P.A., and Schorey, J.S. (2024). Mycobacterium tuberculosis SecA2-dependent activation of host Rig-I\/MAVs signaling is not conserved in Mycobacterium marinum. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0281564"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ramon-Luing, L.A., Palacios, Y., Ruiz, A., T\u00e9llez-Navarrete, N.A., and Chavez-Galan, L. (2023). Virulence Factors of Mycobacterium tuberculosis as Modulators of Cell Death Mechanisms. Pathogens, 12.","DOI":"10.3390\/pathogens12060839"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ni.3434","article-title":"Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism","volume":"17","author":"Ouimet","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ahsan, F., Maertzdorf, J., Guhlich-Bornhof, U., Kaufmann, S.H.E., and Moura-Alves, P. (2018). IL-36\/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-19476-x"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/JLB.4MR0717-277R","article-title":"Mycobacterium tuberculosis: Rewiring host cell signaling to promote infection","volume":"103","author":"Stutz","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Silwal, P., Kim, J.K., Yuk, J.-M., and Jo, E.-K. (2018). AMP-Activated Protein Kinase and Host Defense against Infection. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113495"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Peyron, P., Vaubourgeix, J., Poquet, Y., Levillain, F., Botanch, C., Bardou, F., Daff\u00e9, M., Emile, J.-F., Marchou, B., and Cardona, P.-J. (2008). Foamy macrophages from tuberculous patients\u2019 granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000204"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Agarwal, P., Gordon, S., and Martinez, F.O. (2021). Foam Cell Macrophages in Tuberculosis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.775326"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/imr.12952","article-title":"Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis","volume":"301","author":"Laval","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"Russell","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chen, Z., Kong, X., Ma, Q., Chen, J., Zeng, Y., Liu, H., Wang, X., and Lu, S. (2024). The impact of Mycobacterium tuberculosis on the macrophage cholesterol metabolism pathway. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1402024"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Liu, Y., and Larrouy-Maumus, G. (2022). Lipids and Glycolipids as Biomarkers of Mycobacterial Infections. Biology of Mycobacterial Lipids, Elsevier.","DOI":"10.1016\/B978-0-323-91948-7.00014-2"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e13261","DOI":"10.1111\/sji.13261","article-title":"Polysaccharides and glycolipids of Mycobacterium tuberculosis and their induced immune responses","volume":"97","author":"Gong","year":"2023","journal-title":"Scand. J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/acsinfecdis.2c00075","article-title":"Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis","volume":"8","author":"Brandenburg","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1513\/AnnalsATS.202308-746OC","article-title":"The Impact of Trehalose Dimycolate on the Clinical Course of Mycobacterium avium Complex Pulmonary Disease","volume":"21","author":"Lee","year":"2024","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wang, H., Liu, D., and Zhou, X. (2023). Effect of Mycolic Acids on Host Immunity and Lipid Metabolism. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010396"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Lyu, J., Narum, D.E., Baldwin, S.L., Larsen, S.E., Bai, X., Griffith, D.E., Dartois, V., Naidoo, T., Steyn, A.J.C., and Coler, R.N. (2024). Understanding the development of tuberculous granulomas: Insights into host protection and pathogenesis, a review in humans and animals. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1427559"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Weeratunga, P., Moller, D.R., and Ho, L.-P. (2024). Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis. J. Clin. Investig., 134.","DOI":"10.1172\/JCI175264"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"uqad006","DOI":"10.1093\/femsml\/uqad006","article-title":"Mycobacterium tuberculosis infection triggers epigenetic changes that are enriched in a type I IFN signature","volume":"4","author":"Madden","year":"2023","journal-title":"Microlife"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sounderrajan, V., Rajadas, S.E., Thangam, T., Rao, S.S., Parthasarathy, K., Tamilanban, R., and Harshavardhan, S. (2024). Host-Directed Immunotherapy for Tuberculosis. Translational Research in Biomedical Sciences: Recent Progress and Future Prospects, Springer.","DOI":"10.1007\/978-981-97-1777-4_22"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08830185.2021.1990277","article-title":"Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy","volume":"42","author":"Kalra","year":"2021","journal-title":"Int. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Li, C., Wang, J., Xu, J., Pi, J., and Zheng, B. (2024). Roles of HIF-1\u03b1 signaling in Mycobacterium tuberculosis infection: New targets for anti-TB therapeutics?. Biochem. Biophys. Res. Commun., 711.","DOI":"10.1016\/j.bbrc.2024.149920"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Nan, Y., Wang, Y., Dong, Y., Liu, Y., Ge, X., Chen, Y., Long, M., and Zhou, X. (2024). Impact of Hypoxia-Inducible Factor-1\u03b1 on Host Immune Metabolism and Tissue Damage During Mycobacterium bovis Infection. J. Infect. Dis., jiae305.","DOI":"10.1093\/infdis\/jiae305"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/intimm\/dxae013","article-title":"Metabolic reprogramming and macrophage polarization in granuloma formation","volume":"36","author":"Nakamizo","year":"2024","journal-title":"Int. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Li, Y., Qian, Y., Wang, N., Qiu, D., Cao, H., Wang, Y., Luo, H., Shen, X., Cui, H., and Wang, J. (2023). The functions and applications of extracellular vesicles derived from Mycobacterium tuberculosis. Biomed. Pharmacother., 168.","DOI":"10.1016\/j.biopha.2023.115767"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Alipoor, S.D., and Elieh-Ali-Komi, D. (2024). Significance of extracellular vesicles in orchestration of immune responses in Mycobacterium tuberculosis infection. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1398077"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/jleuko\/qiad037","article-title":"Extracellular vesicles from Mycobacterium tuberculosis\u2013infected neutrophils induce maturation of monocyte-derived dendritic cells and activation of antigen-specific Th1 cells","volume":"113","author":"Peregrino","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Gupta, M.M., Gilhotra, R., Deopa, D., Bhat, A.A., Thapa, R., Singla, N., Kulshrestha, R., and Gupta, G. (2023). Epigenetics of Pulmonary Tuberculosis, In Targeting Epigenetics in Inflammatory Lung Diseases, Springer.","DOI":"10.1007\/978-981-99-4780-5_8"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Thomas, S.S., Abhinand, K., Menon, A.M., Nair, B.G., Kumar, G.B., Arun, K.B., Edison, L.K., and Madhavan, A. (2024). Epigenetic Mechanisms Induced by Mycobacterium tuberculosis to Promote Its Survival in the Host. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111801"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"156693","DOI":"10.1016\/j.cyto.2024.156693","article-title":"Epigenetic modulation of cytokine expression in Mycobacterium tuberculosis-infected monocyte derived-dendritic cells: Implications for tuberculosis diagnosis","volume":"181","author":"Meskini","year":"2024","journal-title":"Cytokine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijtb.2023.05.011","article-title":"Metformin has immunomodulatory effects which support its potential use as adjunctive therapy in tuberculosis","volume":"71","author":"Sutter","year":"2024","journal-title":"Indian J. Tuberc."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhao, L., Fan, K., Sun, X., Li, W., Qin, F., Shi, L., Gao, F., and Zheng, C. (2024). Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1305325"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"106631","DOI":"10.1016\/j.micpath.2024.106631","article-title":"Rapamycin improves the long-term T-cell memory and protective efficacy of tuberculosis subunit vaccine","volume":"190","author":"Niu","year":"2024","journal-title":"Microb. Pathog."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Abnousian, A., Vasquez, J., Sasaninia, K., Kelley, M., and Venketaraman, V. (2023). Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis. Biomedicines, 11.","DOI":"10.20944\/preprints202304.0166.v1"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Nasiri, M.J., Lutfy, K., and Venketaraman, V. (2024). Challenges of Multidrug-Resistant Tuberculosis Meningitis: Current Treatments and the Role of Glutathione as an Adjunct Therapy. Vaccines, 12.","DOI":"10.3390\/vaccines12121397"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Singh, M., Vaughn, C., Sasaninia, K., Yeh, C., Mehta, D., Khieran, I., and Venketaraman, V. (2020). Understanding the relationship between glutathione, TGF-\u03b2, and vitamin D in combating Mycobacterium tuberculosis infections. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092757"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e000866","DOI":"10.1136\/esmoopen-2020-000866","article-title":"Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors","volume":"5","author":"Anand","year":"2020","journal-title":"ESMO Open"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Liu, C.-W., Wu, L.S.-H., Lin, C.-J., Wu, H.-C., Liu, K.-C., and Lee, S.-W. (2024). Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0303431"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S1470-2045(19)30674-6","article-title":"Immune checkpoint inhibitors and tuberculosis: An old disease in a new context","volume":"21","author":"Langan","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"104193","DOI":"10.1016\/j.drudis.2024.104193","article-title":"Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections","volume":"29","author":"Bhat","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kalsum, S., Akber, M., Loreti, M.G., Andersson, B., Danielson, E., Lerm, M., and Brighenti, S. (2024). Sirtuin inhibitors reduce intracellular growth of M. tuberculosis in human macrophages via modulation of host cell immunity. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-79136-1"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mukhtar, F., Guarnieri, A., Brancazio, N., Falcone, M., Di Naro, M., Azeem, M., Zubair, M., Nicolosi, D., Di Marco, R., and Petronio, G.P. (2024). The role of Mycobacterium tuberculosis exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1441781"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ncrna.2024.09.005","article-title":"Recent advances in the development and clinical application of miRNAs in infectious diseases","volume":"10","author":"Nunes","year":"2024","journal-title":"Non-coding RNA Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: Biological functions, diseases and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"102542","DOI":"10.1016\/j.tube.2024.102542","article-title":"Repression of BRD4 mitigates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium-infected macrophages by repressing endoplasmic reticulum stress","volume":"148","author":"Wang","year":"2024","journal-title":"Tuberculosis"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Liang, Y., Tan, X., and Liu, L. (2024). Host long noncoding RNAs in bacterial infections. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1419782"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kotey, S.K., Tan, X., Kinser, A.L., Liu, L., and Cheng, Y. (2024). Host Long Noncoding RNAs as Key Players in Mycobacteria\u2013Host Interactions. Microorganisms, 12.","DOI":"10.3390\/microorganisms12122656"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.3390\/cimb46070449","article-title":"Review on Long Non-Coding RNAs as Biomarkers and Potentially Therapeutic Targets for Bacterial Infections","volume":"46","author":"Shi","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/acsinfecdis.4c00385","article-title":"Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression","volume":"10","author":"Jhilta","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"100300","DOI":"10.1016\/j.jctube.2022.100300","article-title":"Tuberculosis pathophysiology and anti-VEGF intervention","volume":"27","author":"Maison","year":"2022","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"McKell, M.C., Crowther, R.R., Schmidt, S.M., Robillard, M.C., Cantrell, R., Lehn, M.A., Janssen, E.M., and Qualls, J.E. (2021). Promotion of Anti-Tuberculosis Macrophage Activity by L-Arginine in the Absence of Nitric Oxide. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.653571"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e230143","DOI":"10.1590\/0074-02760230143","article-title":"Histone deacetylase (HDAC) inhibitors- based drugs are effective to control Mycobacterium tuberculosis infection and promote the sensibility for rifampicin in MDR strain","volume":"118","year":"2023","journal-title":"Mem. Do Inst. Oswaldo Cruz"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"102062","DOI":"10.1016\/j.tube.2021.102062","article-title":"HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection","volume":"127","author":"Campo","year":"2021","journal-title":"Tuberculosis"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Qin, Y., Li, T., An, P., Ren, Z., Xi, J., and Tang, B. (2024). Important role of DNA methylation hints at significant potential in tuberculosis. Arch. Microbiol., 206.","DOI":"10.1007\/s00203-024-03888-7"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Sampath, P., Periyasamy, K.M., Ranganathan, U.D., and Bethunaickan, R. (2021). Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.667206"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kathamuthu, G.R., Kumar, N.P., Moideen, K., Nair, D., Banurekha, V.V., Sridhar, R., Baskaran, D., and Babu, S. (2020). Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00419"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e2321336121","DOI":"10.1073\/pnas.2321336121","article-title":"Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits","volume":"121","author":"Datta","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1042\/CS20190415","article-title":"Revisiting hypoxia therapies for tuberculosis","volume":"133","author":"Oehlers","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molmed.2024.07.011","article-title":"Leveraging insights from cancer to improve tuberculosis therapy","volume":"31","author":"Datta","year":"2024","journal-title":"Trends Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.ijid.2022.02.043","article-title":"Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis","volume":"124","author":"Nasiri","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e20210384","DOI":"10.36416\/1806-3756\/e20210384","article-title":"Bedaquiline-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis","volume":"48","author":"Hatami","year":"2022","journal-title":"J. Bras. de Pneumol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"108504","DOI":"10.1016\/j.cclet.2023.108504","article-title":"High-throughput fluorescent screening of thioredoxin reductase inhibitors to inhibit Mycobacterium tuberculosis","volume":"35","author":"Yan","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/acsinfecdis.3c00463","article-title":"Identification of Chemical Scaffolds Targeting Drug-Resistant and Latent Mycobacterium tuberculosis through High-Throughput Whole-Cell Screening","volume":"10","author":"Perveen","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Tang, C., Wu, L., Li, M., Dai, J., Shi, Y., Wang, Q., Xu, F., Zheng, L., Xiao, X., and Cai, J. (2024). High-throughput nanopore targeted sequencing for efficient drug resistance assay of Mycobacterium tuberculosis. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1331656"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Shi, L., Gu, R., Long, J., Duan, G., and Yang, H. (2024). Application of CRISPR\u2013cas-based technology for the identification of tuberculosis, drug discovery and vaccine development. Mol. Biol. Rep., 51.","DOI":"10.1007\/s11033-024-09424-6"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-031-56794-0_2","article-title":"Development and analysis of multiscale models for tuberculosis: From molecules to populations","volume":"Volume 2","author":"Nanda","year":"2024","journal-title":"Predicting Pandemics in a Globally Connected World, Toward a Multiscale, Multidisciplinary Framework Through Modeling and Simulation"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Qureshi, H., Shah, Z., Raja, M.A.Z., Alshahrani, M.Y., Khan, W.A., and Shoaib, M. (2024). Machine learning investigation of tuberculosis with medicine immunity impact. Diagn. Microbiol. Infect. Dis., 110.","DOI":"10.1016\/j.diagmicrobio.2024.116472"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00521-022-07258-6","article-title":"Tuberculosis detection in chest radiograph using convolutional neural network architecture and explainable artificial intelligence","volume":"36","author":"Nafisah","year":"2024","journal-title":"Neural Comput. Appl."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jiph.2024.02.012","article-title":"Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Infect. Public Health"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"100033","DOI":"10.1016\/j.meomic.2024.100033","article-title":"The integration of omics: A promising approach to personalized tuberculosis treatment","volume":"12","author":"Guha","year":"2024","journal-title":"Med. Omics"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Otchere, I.D., Aboagye, S.Y., Arthur, P.K., and Asante-Poku, A. (2024). Viewpoint of multi-omics potential in tuberculosis research: Identifying biomarkers for biomanufacturing of efficient control tools. Front. Trop. Dis., 5.","DOI":"10.3389\/fitd.2024.1443248"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Ayaz, O., Ali, A., Ayaz, A., Nazir, A., Ahmad, S.B., Singh, N., Wani, A.B., and Bhat, K.A. (2024). Multiomics technologies applied to tuberculosis drug discovery. Biological Insights of Multi-Omics Technologies in Human Diseases, Elsevier.","DOI":"10.1016\/B978-0-443-23971-7.00011-0"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/4\/1621\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:34:07Z","timestamp":1760027647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/4\/1621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":108,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijms26041621"],"URL":"https:\/\/doi.org\/10.3390\/ijms26041621","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}